Sangamo Biosciences's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Sangamo Biosciences is scheduled to report earnings on May 1, 2024, and the estimated EPS forecast is $-0.21. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 2.04M	$ 9.40M	$ 6.83M	$ 157.96M	$ 27.23M
Gross Profit	$ 2.04M	$ 9.40M	$ 6.83M	$ 157.96M	$ 27.23M
EBIT	$ -60.57M	$ -102.89M	$ -120.77M	$ 21.33M	$ -55.39M
EBITDA	$ -57.86M	$ -95.64M	$ -115.41M	$ 25.86M	$ -50.87M
Net Income Common Stockholders	$ -60.30M	$ -104.19M	$ -114.51M	$ 21.16M	$ -51.97M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 81.00M	$ 132.11M	$ 143.10M	$ 205.39M	$ 277.63M
Total Assets	$ 165.32M	$ 219.70M	$ 325.07M	$ 440.57M	$ 562.51M
Total Debt	$ 33.52M	$ 34.98M	$ 36.37M	$ 37.70M	$ 38.99M
Net Debt	$ -47.49M	$ -97.14M	$ -106.73M	$ -167.69M	$ -238.65M
Total Liabilities	$ 82.43M	$ 84.78M	$ 91.43M	$ 104.96M	$ 267.55M
Stockholders Equity	$ 82.89M	$ 134.92M	$ 233.66M	$ 335.61M	$ 295.00M
Cash Flow	-
Free Cash Flow	$ -53.21M	$ -50.04M	$ -66.25M	$ -76.50M	$ -64.52M
Operating Cash Flow	$ -50.54M	$ -47.29M	$ -60.71M	$ -66.30M	$ -57.05M
Investing Cash Flow	$ 37.71M	$ 37.63M	$ 42.47M	$ 35.73M	$ 42.61M
Financing Cash Flow	$ 167.00K	$ -100.00K	$ 6.52M	$ 8.00M	$ 19.54M

Currency in USD

Sangamo Biosciences Earnings and Revenue History

Income Statement >

Sangamo Biosciences Debt to Assets

Balance Sheet >

Sangamo Biosciences Cash Flow

Cash Flow >

Sangamo Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing